ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

HAE Haemonetics Corp

84.08
-0.57 (-0.67%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 959,786
Bid Price
Ask Price
News -
Day High 85.2924

Low
70.74

52 Week Range

High
97.97

Day Low 82.885
Share Name Share Symbol Market Stock Type
Haemonetics Corp HAE NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-0.57 -0.67% 84.08 19:00:00
Open Price Low Price High Price Close Price Previous Close
84.75 82.885 85.2924 84.08 84.65
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
11,798 959,786 US$ 83.65 US$ 80,283,917 - 70.74 - 97.97
Last Trade Type Quantity Price Currency
18:52:28 25 US$ 84.94 USD

Haemonetics Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.27B 50.79M - 1.17B 115.4M 2.27 37.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Haemonetics News

Date Time Source News Article
5/29/202416:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/29/202415:06Edgar (US Regulatory)Form 8-K - Current report
5/29/202410:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/29/202409:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/28/202415:34Edgar (US Regulatory)Form SD - Specialized disclosure report
5/23/202405:03Edgar (US Regulatory)Form 8-K - Current report
5/23/202405:00PR Newswire (US)Haemonetics Prices Upsized Private Placement of $600 Million..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HAE Message Board. Create One! See More Posts on HAE Message Board See More Message Board Posts

Historical HAE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week89.0589.948182.88587.35793,720-4.97-5.58%
1 Month94.5297.9782.88591.12716,965-10.44-11.05%
3 Months78.0097.9772.8686.80534,4936.087.79%
6 Months80.8097.9770.7483.32464,1583.284.06%
1 Year83.4297.9770.7485.02375,7600.660.79%
3 Years55.9497.9743.5071.61447,27928.1450.30%
5 Years96.87142.1143.5083.83478,122-12.79-13.20%

Haemonetics Description

Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in three categories: Plasma, Blood Center and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood. Hospital, which is comprised of Hemostasis Management, Cell Salvage, Transfusion Management and Vascular Closure products, includes devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, specialized blood cell processing systems and disposables, blood transfusion management software and vascular closure devices.

Your Recent History

Delayed Upgrade Clock